Hostname: page-component-8448b6f56d-xtgtn Total loading time: 0 Render date: 2024-04-23T10:38:33.293Z Has data issue: false hasContentIssue false
  • English
  • Français

Oxidative stress, inflammation and cognitive impairment in first psychotic patients

Published online by Cambridge University Press:  16 April 2020

M. Martínez-Cengotitabengoa ,
J.C. Leza ,
S. Alberich ,
S. Barbeito ,
R. González-Oliveros ,
I. Zorrilla ,
I. de la Rosa ,
L. Celaya ,
S. Gubbini  and
A. González-Pinto
M. Martínez-Cengotitabengoa
Affiliation:
Psychiatry Research Unit, CIBERSAM, Santiago Apostol Hospital, Vitoria, Spain
J.C. Leza
Affiliation:
CIBERSAM, Universidad Complutense de Madrid, Madrid, Spain
S. Alberich
Affiliation:
Psychiatry Research Unit, CIBERSAM, Santiago Apostol Hospital, Vitoria, Spain
S. Barbeito
Affiliation:
Psychiatry Research Unit, CIBERSAM, Santiago Apostol Hospital, Vitoria, Spain
R. González-Oliveros
Affiliation:
Psychiatry, Santiago Hospital, Vitoria, Spain
I. Zorrilla
Affiliation:
Psychiatry, Santiago Hospital, Vitoria, Spain
I. de la Rosa
Affiliation:
Psychiatry, Santiago Hospital, Vitoria, Spain
L. Celaya
Affiliation:
Psychiatry, Santiago Hospital, Vitoria, Spain
S. Gubbini
Affiliation:
Santiago Apostol Hospital, Vitoria, Spain
A. González-Pinto
Affiliation:
Psychiatry, CIBERSAM, Santiago Apostol Hospital, University of the Basque Country, Vitoria, Spain

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Both oxidative stress and the inflammatory chemokine MCP-1 have been linked to the pathophysiology of certain mental illnesses such as psychosis. There are previous studies in rats and dogs suggesting that oxidative stress can cause cognitive impairment.

Objectives

To correlate oxidative stress and the chemokine MCP-1 levels with cognitive impairment in first episode psychosis.

Methods

28 patients with first episode psychosis and 28 healthy controls matched by sex and age were included in the study, who were given a battery of neurocognitive tests and we determined their blood levels of lipid peroxidation (TBARS), nitric oxide, total antioxidant status (TAS), glutathione, activity of enzymes catalase (CAT), glutathione peroxidase (cGPx) and superoxide dismutase (SOD) and the inflammatory chemokine MCP-1.

Results

Healthy controls had better TAS than patients and increased activity of enzymes cGPx and CAT.

We found a statistically significant negative relationship between levels of MCP-1 and working memory, attention and verbal memory. At higher levels of chemokines, worse cognitive functioning in these areas.

Verbal memory was also negatively related, in a meaningful way, with nitric oxide levels in blood.

Likewise, we found that higher levels of glutathione correlated with better scores on the 3 tests performed of verbal fluency.

Conclusions

In patients with a PEP, levels of certain markers of oxidative stress and inflammation are associated with poorer cognitive functioning.

Type
P01-423
Information
European Psychiatry , Volume 26 , Issue S2: Abstracts of the 19th European Congress of Psychiatry , March 2011 , pp. 427
Copyright
Copyright © European Psychiatric Association2011
Submit a response

Comments

No Comments have been published for this article.